Antacids Market Size, Share and Industry Analysis, Report 2024-2032

The latest report by IMARC Group, titled" 𝐀𝐧𝐭𝐚𝐜𝐢𝐝𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐛𝐲 𝐃𝐫𝐮𝐠 𝐂𝐥𝐚𝐬𝐬 (𝐏𝐫𝐨𝐭𝐨𝐧 𝐏𝐮𝐦𝐩 𝐈𝐧𝐡𝐢𝐛𝐢𝐭𝐨𝐫𝐬, 𝐇𝟐 𝐀𝐧𝐭𝐚𝐠𝐨𝐧𝐢𝐬𝐭, 𝐀𝐜𝐢𝐝 𝐍𝐞𝐮𝐭𝐫𝐚𝐥𝐢𝐳𝐞𝐫𝐬, 𝐏𝐫𝐨-𝐌𝐨𝐭𝐢𝐥𝐢𝐭𝐲 𝐀𝐠𝐞𝐧𝐭𝐬), 𝐅𝐨𝐫𝐦𝐮𝐥𝐚𝐭𝐢𝐨𝐧 𝐓𝐲𝐩𝐞 (𝐓𝐚𝐛𝐥𝐞𝐭, 𝐋𝐢𝐪𝐮𝐢𝐝, 𝐏𝐨𝐰𝐝𝐞𝐫, 𝐚𝐧𝐝 𝐎𝐭𝐡𝐞𝐫𝐬), 𝐃𝐢𝐬𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧 𝐂𝐡𝐚𝐧𝐧𝐞𝐥 (𝐇𝐨𝐬𝐩𝐢𝐭𝐚𝐥 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐢𝐞𝐬, 𝐑𝐞𝐭𝐚𝐢𝐥 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐢𝐞𝐬, 𝐚𝐧𝐝 𝐎𝐭𝐡𝐞𝐫𝐬), 𝐚𝐧𝐝 𝐑𝐞𝐠𝐢𝐨𝐧 𝟐𝟎𝟐𝟒-𝟐𝟎𝟑𝟐
", offers a comprehensive analysis of the industry, which comprises insights on the market. The global antacids market size reached US$ 6.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.5 Billion by 2032, exhibiting a growth rate (CAGR) of 3.5% during 2024-2032.

𝐅𝐚𝐜𝐭𝐨𝐫𝐬 𝐀𝐟𝐟𝐞𝐜𝐭𝐢𝐧𝐠 𝐭𝐡𝐞 𝐆𝐫𝐨𝐰𝐭𝐡 𝐨𝐟 𝐭𝐡𝐞 𝐀𝐧𝐭𝐚𝐜𝐢𝐝𝐬 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲:

𝐏𝐫𝐞𝐯𝐚𝐥𝐞𝐧𝐜𝐞 𝐨𝐟 𝐆𝐚𝐬𝐭𝐫𝐨𝐢𝐧𝐭𝐞𝐬𝐭𝐢𝐧𝐚𝐥 𝐃𝐢𝐬𝐨𝐫𝐝𝐞𝐫𝐬:

Gastrointestinal (GI) disorders, such as acid reflux, indigestion, and peptic ulcers, are widespread worldwide. These conditions affect millions of individuals, contributing significantly to the demand for antacids. Factors such as unhealthy diets, stress, and lifestyle changes have increased the incidence of these disorders. Antacids provide quick relief by neutralizing stomach acid and alleviating symptoms such as heartburn and discomfort. As dietary habits and stress levels continue to fluctuate globally, the need for effective and accessible antacid treatments remains high. Furthermore, the aging population is prone to developing GI issues, adding to the steady demand for antacids. Elderly individuals often experience decreased stomach function and increased susceptibility to acid-related problems, thereby relying on antacids for symptom management. Pharmaceutical advancements in antacid formulations cater to these specific needs, offering targeted relief and improved efficacy.

𝐂𝐨𝐧𝐬𝐮𝐦𝐞𝐫 𝐏𝐫𝐞𝐟𝐞𝐫𝐞𝐧𝐜𝐞 𝐟𝐨𝐫 𝐎𝐯𝐞𝐫-𝐭𝐡𝐞-𝐂𝐨𝐮𝐧𝐭𝐞𝐫 (𝐎𝐓𝐂) 𝐌𝐞𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬:

There is a notable consumer preference for OTC medications such as antacids due to their convenience, accessibility, and perceived safety. Many individuals prefer to self-diagnose and treat mild GI symptoms independently rather than seeking prescription medications or medical consultation. Antacids fit well within this consumer behavior pattern as they are readily available in pharmacies, supermarkets, and online platforms without requiring a prescription of the doctor. The ease of access to antacids aligns with modern lifestyles where convenience plays a crucial role in consumer decision-making. Moreover, OTC antacids offer quick relief, making them popular choices for managing occasional symptoms such as heartburn after indulging in rich foods or experiencing stress.

𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐦𝐞𝐧𝐭𝐬 𝐢𝐧 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭:

Technological advancements play a pivotal role in shaping the global antacids market. Pharmaceutical companies continuously invest in research and development to enhance antacid formulations, making them more effective, fast-acting, and long-lasting. Innovations include the incorporation of new ingredients, such as alginate formulations that provide a protective barrier against stomach acid, or dual-action antacids that combine acid neutralization with acid production inhibition. Additionally, advancements in manufacturing processes ensure product consistency, purity, and shelf stability, meeting regulatory standards across different regions. These technological improvements enhance the therapeutic efficacy of antacids and also improve patient compliance and satisfaction.

For an in-depth analysis, you can request a sample copy of the report: https://www.imarcgroup.com/antacids-market/requestsample

𝐋𝐞𝐚𝐝𝐢𝐧𝐠 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐞 𝐆𝐥𝐨𝐛𝐚𝐥 𝐀𝐧𝐭𝐚𝐜𝐢𝐝𝐬 𝐌𝐚𝐫𝐤𝐞𝐭

• Abbott Laboratories
• AstraZeneca plc
• Bayer AG
• Boehringer Ingelheim International GmbH
• Dr. Reddy's Laboratories Ltd.
• GlaxoSmithKline plc
• Johnson & Johnson
• Pfizer Inc.
• Procter & Gamble Company
• Reckitt Benckiser Group PLC
• Sanofi S.A.
• Sun Pharmaceutical Industries Ltd.
• Takeda Pharmaceutical Company Limited.

𝗔𝗻𝘁𝗮𝗰𝗶𝗱𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 𝗥𝗲𝗽𝗼𝗿𝘁 𝗦𝗲𝗴𝗺𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻:

𝐁𝐲 𝐃𝐫𝐮𝐠 𝐂𝐥𝐚𝐬𝐬:

• Proton Pump Inhibitors
• H2 Antagonist
• Acid Neutralizers
• Pro-Motility Agents

Proton pump inhibitors dominate the market due to their potent acid-suppressing abilities and widespread prescription for treating conditions such as gastroesophageal reflux disease (GERD) and peptic ulcers.

𝐁𝐲 𝐅𝐨𝐫𝐦𝐮𝐥𝐚𝐭𝐢𝐨𝐧 𝐓𝐲𝐩𝐞:

• Tablet
• Liquid
• Powder
• Others

Tablet represents the largest segment due to their convenience, ease of manufacturing, stable shelf life, and patient familiarity with oral solid dosage forms.

Browse full report: https://www.imarcgroup.com/antacids-market

𝐁𝐲 𝐃𝐢𝐬𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧 𝐂𝐡𝐚𝐧𝐧𝐞𝐥:

• Hospital Pharmacies
• Retail Pharmacies
• Others

Retail pharmacies hold maximum number of shares as they offer convenient access to over-the-counter and prescription medications, including antacids, catering to a broad consumer base seeking immediate relief and professional advice.

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

Asia Pacific's dominance in the antacids market is attributed to its large and diverse population, increasing incidence of gastrointestinal disorders, rising healthcare expenditure, and expanding access to healthcare services across countries in the region.

𝐆𝐥𝐨𝐛𝐚𝐥 𝐀𝐧𝐭𝐚𝐜𝐢𝐝𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬:

Shifting dietary habits, characterized by increased consumption of spicy, fatty, and acidic foods, contribute significantly to the demand for antacids. Modern diets, often high in processed foods and carbonated beverages, are known triggers for acid reflux and indigestion, prompting individuals to seek relief through antacid medications. Additionally, rising health awareness and an increasing emphasis on preventive healthcare drive consumers to seek prompt treatment for gastrointestinal discomfort. Individuals are more proactive in managing their health, leading to higher demand for effective antacid solutions that alleviate symptoms quickly and effectively without significant side effects.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐨𝐭𝐡𝐞𝐫 𝐑𝐞𝐩𝐨𝐫𝐭𝐬

lawn and garden consumables market: https://www.imarcgroup.com/lawn-garden-consumables-market
security information and event management siem market: https://www.imarcgroup.com/security-information-event-management-market
well cementing services market: https://www.imarcgroup.com/well-cementing-services-market
healthcare cognitive computing market: https://www.imarcgroup.com/healthcare-cognitive-computing-market
cold heading machine market: https://www.imarcgroup.com/cold-heading-machine-market

𝑰𝒇 𝒚𝒐𝒖 𝒓𝒆𝒒𝒖𝒊𝒓𝒆 𝒂𝒏𝒚 𝒔𝒑𝒆𝒄𝒊𝒇𝒊𝒄 𝒊𝒏𝒇𝒐𝒓𝒎𝒂𝒕𝒊𝒐𝒏 𝒕𝒉𝒂𝒕 𝒊𝒔 𝒏𝒐𝒕 𝒄𝒐𝒗𝒆𝒓𝒆𝒅 𝒄𝒖𝒓𝒓𝒆𝒏𝒕𝒍𝒚 𝒘𝒊𝒕𝒉𝒊𝒏 𝒕𝒉𝒆 𝒔𝒄𝒐𝒑𝒆 𝒐𝒇 𝒕𝒉𝒆 𝒓𝒆𝒑𝒐𝒓𝒕, 𝒘𝒆 𝒘𝒊𝒍𝒍 𝒑𝒓𝒐𝒗𝒊𝒅𝒆 𝒕𝒉𝒆 𝒔𝒂𝒎𝒆 𝒂𝒔 𝒂 𝒑𝒂𝒓𝒕 𝒐𝒇 𝒕𝒉𝒆 𝒄𝒖𝒔𝒕𝒐𝒎𝒊𝒛𝒂𝒕𝒊𝒐𝒏.

Contact Us

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic, and technological developments for business leaders in pharmaceutical, industrial, and high-technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology, and novel processing methods are at the top of the company's expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

This release was published on openPR.